Roche considering sale of Diabetes Care unit ($5bn)

Roche Holding AG is reportedly considering selling – partially or totally – its Diabetes Care business unit, similarly to other groups – including J&J – which also appear determined to leave the diabetes business, due to the drop in prices in the last years. The Swiss group has stated it could even explore the option of creating a spin-off of the unit. The unit could reach a value of approximately $5bn, though this could be affected by the decline in the unit’s sales volume in the first nine months of the year (-3%), analysts say. (Source Bloomberg)